Items where authors include "Heslop, P."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Flynn, S., Hatton, C., Hastings, R. et al. (9 more authors) (2022) Access to and use of health and social care services for people with learning disabilities during COVID-19: a longitudinal study. Tizard Learning Disability Review, 27 (1). pp. 57-66. ISSN 1359-5474

Ni Lochlainn, M., Cox, N.J., Wilson, T. et al. (23 more authors) (2021) Nutrition and frailty : opportunities for prevention and treatment. Nutrients, 13 (7). 2349.

Monograph

Flynn, S., Hayden, N. orcid.org/0000-0003-1104-3885, Clarke, L. et al. (18 more authors) (2021) Coronavirus and people with learning disabilities study: wave 3 results: September 2023 (Full Report). Report. University of Warwick , Coventry, UK.